Genetico Research & Diagnostics
Delhi
About Genetico Research & Diagnostics
Genetico is Asia’s first and leading AI-enabled clinical platform designed specifically for the management of rare and genetic diseases. The platform addresses the data and workflow challenges faced by clinical geneticists by enabling structured capture, organization, and longitudinal management of complex genetic information. Genetico supports end-to-end genetic workflows, including patient records, pedigree management, phenotype and genotype documentation, and registry-ready data capture. Its AI-assisted capabilities, such as free-text to HPO mapping, OCR-based report extraction, phenotype analysis, disease ranking, and differential diagnosis, are designed to reduce cognitive and administrative burden while keeping clinicians in full control of clinical decisions. The platform is trusted by leading Centres of Excellence and clinicians in clinical genetics and rare disease care and is backed by institutional partners, government grants, and recognized incubators. Built by a multidisciplinary team spanning clinical genetics, bioinformatics, artificial intelligence, and health systems, Genetico aims to serve as foundational infrastructure for high-quality rare disease data, enabling clinical care, research, registries, and early diagnosis initiatives at scale.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $26.3K
- Last round: Series Unknown (Mar 2024)
- Website: genetico.in
Industries & Categories
Biotechnology, Health Care, Life Science
Social Profiles
Canonical: https://fsome.com/organization/genetico-research-diagnostics-126387 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.